SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000020
Filing Date
2024-02-16
Accepted
2024-02-16 16:12:45
Documents
15
Period of Report
2024-02-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240213.htm   iXBRL 8-K 36372
2 EX-99.1 lifecore-pressrelease.htm EX-99.1 12502
  Complete submission text file 0001005286-24-000020.txt   181394

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240213.xsd EX-101.SCH 1983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240213_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240213_pre.xml EX-101.PRE 12591
16 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240213_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 24648466
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)